Low Blood Lead Levels Associated with Clinically Diagnosed Attention-deficit/hyperactivity Disorder and Mediated by Weak Cognitive Control

Overview

Journal Biol Psychiatry

Publisher Elsevier

Specialty Psychiatry

Date 2007 Sep 18

PMID 17868654

Citations 81

Authors

Joel T Nigg

G Mark Knottnerus

Michelle M Martel

Molly Nikolas

Kevin Cavanagh

Wilfried Karmaus

Marsha D Rappley

Affiliations

Soon will be listed here.

Abstract

Background: Attention-deficit/hyperactivity disorder (ADHD) and low-level lead exposure are high-prevalence conditions among children, and studies of large populations have suggested that these conditions are related. We examine this relationship in children from a community sample exposed to average background levels of lead who have a diagnosis of ADHD that is established by clinical criteria.

Methods: One hundred fifty children ages 8-17 years participated (mean age = 14 years; 53 control subjects, 47 ADHD Predominantly Inattentive type, 50 ADHD-Combined type). Diagnosis was formally established with a semi-structured clinical interview and parent and teacher ratings. Children completed intelligence quotient (IQ) measures and the stop task (a neuropsychological measure). Lead was assayed from whole blood with inductively coupled plasma mass spectrometry.

Results: Blood lead levels in this sample closely matched US population exposure averages, with a maximum level of 3.4 mug/dL. Blood lead levels were statistically significantly higher in ADHD-combined type than in non-ADHD control (p < .05) children. Blood lead was associated with symptoms of hyperactivity-impulsivity but not inattention-disorganization, after control of covariates. Blood lead levels were linked with a lower IQ (p < .05), but IQ did not account for effects on hyperactivity. Instead, hyperactivity mediated effects of lead on IQ. Effects of blood lead on hyperactivity-impulsivity were mediated by poor performance on the stop task. This mediation effect was independent of effects of lead on IQ.

Conclusions: Low-level lead exposure might be an important contributor to ADHD. Its effects seem to be mediated by less effective cognitive control, consistent with a route of influence via striatal-frontal neural circuits.

Citing Articles

The Role of Prenatal Exposure to Lead and Manganese in Child Cognitive Neurodevelopment at 18 Months: The Results of the Italian PHIME Cohort.

Rosolen V, Barbiero F, Mariuz M, Parpinel M, Ronfani L, Vecchi Brumatti L Toxics. 2025; 13(1).

PMID: 39853052 PMC: 11768919. DOI: 10.3390/toxics13010054.

Beyond the Brain: Attention Deficit/Hyperactivity Disorder and the Gut-Brain Axis.

Gandhi D, Pande D, Harikrishna A, Advilkar A, Basavan I, Ansari R Cureus. 2025; 16(12):e76291.

PMID: 39850178 PMC: 11754923. DOI: 10.7759/cureus.76291.

Effects of Blood Lead Levels <10 µg/dL in School-Age Children and Adolescents: A Scoping Review.

Pennington A, Smith M, Chuke S, Cornwell C, Allwood P, Courtney J Pediatrics. 2024; 154(Suppl 2).

PMID: 39352036 PMC: 11610497. DOI: 10.1542/peds.2024-067808F.

Exploring the link between toxic metal exposure and ADHD: a systematic review of pb and hg.

Farmani R, Mehrpour O, Kooshki A, Nakhaee S J Neurodev Disord. 2024; 16(1):44.

PMID: 39090571 PMC: 11292919. DOI: 10.1186/s11689-024-09555-8.

An Industry-Relevant Metal Mixture, Iron Status, and Reported Attention-Related Behaviors in Italian Adolescents.

Schildroth S, Kordas K, White R, Friedman A, Placidi D, Smith D Environ Health Perspect. 2024; 132(2):27008.

PMID: 38363634 PMC: 10871126. DOI: 10.1289/EHP12988.

References

Purcell S . Variance components models for gene-environment interaction in twin analysis. Twin Res. 2003; 5(6):554-71. DOI: 10.1375/136905202762342026. View

Braun J, Kahn R, Froehlich T, Auinger P, Lanphear B . Exposures to environmental toxicants and attention deficit hyperactivity disorder in U.S. children. Environ Health Perspect. 2006; 114(12):1904-9. PMC: 1764142. DOI: 10.1289/ehp.9478. View

Cory-Slechta D . Lead-induced impairments in complex cognitive function: offerings from experimental studies. Child Neuropsychol. 2003; 9(1):54-75. DOI: 10.1076/chin.9.1.54.14499. View

Fewtrell L, Pruss-Ustun A, Landrigan P, Ayuso-Mateos J . Estimating the global burden of disease of mild mental retardation and cardiovascular diseases from environmental lead exposure. Environ Res. 2004; 94(2):120-33. DOI: 10.1016/s0013-9351(03)00132-4. View

Lewis M, Pitts D . Inorganic lead exposure in the rat activates striatal cFOS expression at lower blood levels and inhibits amphetamine-induced cFOS expression at higher blood levels. J Pharmacol Exp Ther. 2004; 310(2):815-20. DOI: 10.1124/jpet.103.063941. View

Canfield R, Gendle M, Cory-Slechta D . Impaired neuropsychological functioning in lead-exposed children. Dev Neuropsychol. 2004; 26(1):513-40. DOI: 10.1207/s15326942dn2601_8. View

David O, Hoffman S, Sverd J, Clark J . Lead and hyperactivity: lead levels among hyperactive children. J Abnorm Child Psychol. 1977; 5(4):405-16. DOI: 10.1007/BF00915088. View

Gittelman R, Eskenazi B . Lead and hyperactivity revisited. An investigation of nondisadvantaged children. Arch Gen Psychiatry. 1983; 40(8):827-33. DOI: 10.1001/archpsyc.1983.01790070017002. View

Baron R, Kenny D . The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986; 51(6):1173-82. DOI: 10.1037//0022-3514.51.6.1173. View

10.

Silva P, Hughes P, Williams S, Faed J . Blood lead, intelligence, reading attainment, and behaviour in eleven year old children in Dunedin, New Zealand. J Child Psychol Psychiatry. 1988; 29(1):43-52. DOI: 10.1111/j.1469-7610.1988.tb00687.x. View

11.

Thomson G, Raab G, Hepburn W, Hunter R, Fulton M, Laxen D . Blood-lead levels and children's behaviour--results from the Edinburgh Lead Study. J Child Psychol Psychiatry. 1989; 30(4):515-28. DOI: 10.1111/j.1469-7610.1989.tb00265.x. View

12.

Minder B, Brand E, Orlebeke J . Exposure to lead and specific attentional problems in schoolchildren. J Learn Disabil. 1994; 27(6):393-9. DOI: 10.1177/002221949402700606. View

13.

Lahey B, Applegate B, McBurnett K, Biederman J, Greenhill L, Hynd G . DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents. Am J Psychiatry. 1994; 151(11):1673-85. DOI: 10.1176/ajp.151.11.1673. View

14.

Cory-Slechta D . Relationships between lead-induced learning impairments and changes in dopaminergic, cholinergic, and glutamatergic neurotransmitter system functions. Annu Rev Pharmacol Toxicol. 1995; 35:391-415. DOI: 10.1146/annurev.pa.35.040195.002135. View

15.

Kala S, Jadhav A . Low level lead exposure decreases in vivo release of dopamine in the rat nucleus accumbens: a microdialysis study. J Neurochem. 1995; 65(4):1631-5. DOI: 10.1046/j.1471-4159.1995.65041631.x. View

16.

Tuthill R . Hair lead levels related to children's classroom attention-deficit behavior. Arch Environ Health. 1996; 51(3):214-20. DOI: 10.1080/00039896.1996.9936018. View

17.

MacKinnon D . Analysis of mediating variables in prevention and intervention research. NIDA Res Monogr. 1994; 139:127-53. View

18.

Barkley R . Attention-deficit/hyperactivity disorder, self-regulation, and time: toward a more comprehensive theory. J Dev Behav Pediatr. 1997; 18(4):271-9. View

19.

Jadhav A, Ramesh G . Pb-induced alterations in tyrosine hydroxylase activity in rat brain. Mol Cell Biochem. 1997; 175(1-2):137-41. DOI: 10.1023/a:1006891830182. View

20.

Hu H, Rabinowitz M, Smith D . Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. Environ Health Perspect. 1998; 106(1):1-8. PMC: 1532948. DOI: 10.1289/ehp.981061. View